Search Within

Heiko Schoder

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (61)
  3. Book Section (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (132)
  2. Molecular Imaging and Therapy Service (132)
  3. Radiology, Department of (132)
  4. Solid Tumor Oncology Division (132)
  5. Survivorship Research (61)
  6. Epidemiology and Biostatistics (60)

More Groups

People
  1. John Humm (38)
  2. Nancy Lee (32)
  3. Steven Larson (32)
  4. Eric Sherman (30)
  5. Howard Scher (25)
  6. Michael Morris (25)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (11)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. International Journal of Radiation Oncology, Biology, Physics (17)
  3. Journal of Nuclear Medicine (15)
  4. Blood (8)
  5. Clinical Cancer Research (4)
  6. European Journal of Nuclear Medicine and Molecular Imaging (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Inc. (22)
  3. Society of Nuclear Medicine (15)
  4. Springer (13)
  5. American Society of Hematology (8)
  6. American Association for Cancer Research (7)

More Publishers

Results (132)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics, biodistribution, and radiation dosimetry for (89)Zr-trastuzumab in patients with esophagogastric cancer
    Journal Article

    O'Donoghue, J. A.; Lewis, J. S.; Pandit-Taskar, N.; Fleming, S. E.; Schòˆder, H.; Larson, S. M.; Beylergil, V.; Ruan, S.; Lyashchenko, S. K.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)
    Meeting Abstract

    Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A personalized approach using hypoxia resolution to guide curative-intent radiation therapy dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers treated with concurrent chemoradiation therapy
    Meeting Abstract

    Riaz, N.; Sherman, E.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J. O.; Singh, B.; Morris, L.; Wong, R. J.; Tsai, C. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma
    Meeting Abstract

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: The Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Won, E.; Shah, M. A.; Schòˆder, H.; Strong, V. E.; Coit, D. G.; Brennan, M. F.; Kelsen, D. P.; Janjigian, Y. Y.; Tang, L. H.; Capanu, M.; more...
    Journal of Gastrointestinal Oncology (2016)

    Fulltext@MSK | Save
  • Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N.; Schoder, H.; Beattie, B.; Lanning, R.; Riaz, N.; McBride, S.; Katabi, N.; Li, D.; Yarusi, B.; Chan, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save